Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5490 Target Snapshot

Rho-associated protein kinase 2 · SINGLE PROTEIN · Rattus norvegicus

89Compounds
59Assays
0Approved Drugs
15.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q62868. Use UniProt Q62868 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q62868 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Rho-associated protein kinase 2 as ChEMBL target CHEMBL5490, mapped to UniProt Q62868. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Rho-associated protein kinase 2
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL5490
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q62868
Rho-associated protein kinase 2
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Rho-associated protein kinase 2 is the right protein anchor across sources, using UniProt Q62868 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelRho-associated protein kinase 2
UniProt AccessionQ62868
Component TypeProtein
Sequence Length1388 aa

Rho-associated protein kinase 2

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Rho-associated protein kinase 2, mapped to UniProt Q62868. Sequence length is 1388 aa.

Mapped IDQ62868
Review nameRho-associated protein kinase 2
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

1
Phase III
Assay Mix

Activity Type Distribution

IC5015.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3221812 7.5 IC50 32.0 Preclinical
CHEMBL3221808 7.37 IC50 43.0 Preclinical
CHEMBL5281208 6.62 IC50 240.0 Preclinical
CHEMBL104264 6.57 IC50 270.0 Preclinical
CHEMBL3221810 6.39 IC50 411.0 Preclinical
CHEMBL3221816 6.29 IC50 519.0 Preclinical
CHEMBL559147 6.1 IC50 800.0 Preclinical
CHEMBL3221814 6.05 IC50 900.0 Preclinical
CHEMBL38380 5.72 IC50 1900.0 Clinical
Distribution

pChEMBL Value Distribution

0
5.0
1
5.5
4
6.0
2
6.5
1
7.0
1
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

59
Total Assays
9
Tested Compounds
2
Assay Types
Binding — 58 assays, 9 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 26 0
assay format 18 0
cell-based format 11 9 6.5
organism-based format 3 0
Functional — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
organism-based format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine